Kevin Kalinsky, MD, MS, FASCO

Winship Cancer Institute of Emory University

Latest Videos

Advanced cancer specialists discussing innovative treatment options for HR+ metastatic breast cancer at OncUpdates conference.

Breast Cancer

03/02/2026

Standard of Care Treatments for HR+ Metastatic Breast Cancer

Kevin Kalinsky, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

1. AlT text: Expert discussion on managing breast cancer relapse with adjuvant CDK4/6 inhibitor therapy in ER-positive cases, featuring Dr. Sarah Premji and Dr. Kevin Kalinsky.

HR+ Disease

12/18/2025

SABCS 2025: Evolving Role of CDK4/6 Inhibitors and SERDs in ER-Positive Breast Cancer

Kevin Kalinsky, MD, MS, FASCOSarah Premji, MD